Prosecution Insights
Last updated: April 19, 2026

Nuritas Limited

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18451560 ANTI-INFLAMMATORY PEPTIDES, AND USES THEREOF KOMATSU, LI N 1658 Final Rejection Aug 17, 2023
17795331 TREATMENT OF PANX1 ASSOCIATES DISEASES KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Final Rejection Jul 26, 2022
17635796 PEPTIDES FOR TREATING MUSCLE ATROPHY KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Non-Final OA Feb 16, 2022

Managing Nuritas Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month